AvenCell

Developer of T cell-based immunotherapies intended to support cancer treatment. The company focuses on building chimeric antigen receptor T cells for precise targeting of cancer antigens to overcome t...

Healthcare

Watertown, MA, United States

Founded 2021

68 employees

Website

Valuation

$227M

Market implied

Share Price

N/A

Total Raised

$177.8M

Last Round

N/A

Investors

+8 other investors

View all 8 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock AvenCell's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required